Because in our cohort, the severity of albuminuria in early-stage DN patients is comparatively lower (urinary mAlb/Cr is ∼34.8 ± 15.3 mg/g), it is uncertain if plasma heparanase is significantly associated with in advanced DN patients. This evidence concerns the gene HPSE and liver dysplastic nodule.